This award recognizes three early-career authors, highlighting their exceptional research published in the journal and the profound impact it has had on the field of molecular pharmaceutics. Learn about the 2025 winners and their research.
We are pleased to announce the winners of the 2025 Molecular Pharmaceutics Early Career Best Paper Award. The winners were selected based on the quality and potential impact of their research recently published in Molecular Pharmaceutics. Our winners are early career scientists (<10 years post Ph.D.) from one of three major geographical regions (the Americas, Europe/Middle East/Africa (EMEA), and Asia Pacific).
We received a significant number of nominations. The selection committee was impressed by the exceptionally high quality of the candidates. We thank everyone who submitted nominations for the 2025 Molecular Pharmaceutics Early Career Best Paper Award.
We are excited to announce the 2025 winners from each region:
- Dr. Sergio Martin Saldaña (EMEA)
- Ms. Thu A. Hoang (Asia Pacific)
- Dr. John Gleeson (Americas)
As part of the award, the winners will present their research as part of ACS Publications' Winners Week 2025 webinar series in June 2025 (details to come).
Read on to learn more about each recipient and read their winning papers.
Dr. Sergio Martin Saldaña
Winning Article: Therapeutic Polymer-Based Cannabidiol Formulation: Tackling Neuroinflammation Associated with Ischemic Events in the Brain
Dr. Sergio Martin Saldaña is currently a researcher at the Centro de Investigación Biomédica en Red in Madrid, Spain (Biomaterials Group at Instituto de Ciencia y Tecnología de Polímeros – CSIC).
Ms. Thu A. Hoang
Winning Article: Quantifying the Lymphatic Transport of Model Therapeutics from the Brain in Rats
Ms. Thu A Hoang is currently a Ph.D. candidate at Monash University and a clinical pharmacist at the Royal Women’s Hospital, both in Melbourne, Australia.
Dr. John Gleeson
Winning Article: Head-to-Head Comparison of Caco-2 Transwell and Gut-on-a-Chip Models for Assessing Oral Peptide Formulations
Dr. John Gleeson is an Associate Principal Scientist at Merck in Rahway, New Jersey, United States.
Learn About Last Year's Winners
Meet the Winners of the 2024 Molecular Pharmaceutics Early Career Best Paper Award
ACS Publications is proud to announce Dr. Atabak Ghanizadeh Tabriz, Dr. Huyen Tran, and Dr. Piyushkumar Gondaliya as the winners of the 2024 Molecular Pharmaceutics Early Career Best Paper Award.
